California Public Employees Retirement System Trims Stake in Encompass Health Corporation $EHC

California Public Employees Retirement System lowered its position in Encompass Health Corporation (NYSE:EHC) by 9.0% during the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 240,225 shares of the company’s stock after selling 23,674 shares during the quarter. California Public Employees Retirement System’s holdings in Encompass Health were worth $23,237,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently made changes to their positions in the company. WPG Advisers LLC boosted its stake in Encompass Health by 73.3% during the fourth quarter. WPG Advisers LLC now owns 324 shares of the company’s stock valued at $34,000 after buying an additional 137 shares during the period. Flagship Harbor Advisors LLC bought a new position in Encompass Health in the 4th quarter worth about $37,000. Assetmark Inc. raised its holdings in shares of Encompass Health by 89.6% in the 1st quarter. Assetmark Inc. now owns 455 shares of the company’s stock valued at $44,000 after acquiring an additional 215 shares in the last quarter. Caitong International Asset Management Co. Ltd boosted its position in shares of Encompass Health by 36,200.0% during the 3rd quarter. Caitong International Asset Management Co. Ltd now owns 363 shares of the company’s stock valued at $46,000 after acquiring an additional 362 shares during the last quarter. Finally, Aster Capital Management DIFC Ltd purchased a new position in shares of Encompass Health during the fourth quarter worth about $55,000. Hedge funds and other institutional investors own 97.25% of the company’s stock.

Encompass Health Price Performance

EHC opened at $111.04 on Thursday. The company has a debt-to-equity ratio of 0.76, a current ratio of 1.17 and a quick ratio of 1.17. The stock’s 50 day simple moving average is $104.77 and its 200 day simple moving average is $103.70. The firm has a market cap of $11.01 billion, a price-to-earnings ratio of 18.54, a PEG ratio of 2.44 and a beta of 0.74. Encompass Health Corporation has a 1 year low of $92.77 and a 1 year high of $127.99.

Encompass Health (NYSE:EHC) last released its quarterly earnings data on Thursday, April 30th. The company reported $1.60 earnings per share for the quarter, beating analysts’ consensus estimates of $1.51 by $0.09. Encompass Health had a return on equity of 18.28% and a net margin of 10.04%.The firm had revenue of $1.59 billion during the quarter, compared to analyst estimates of $1.57 billion. During the same quarter in the prior year, the firm posted $1.37 earnings per share. The business’s quarterly revenue was up 9.0% compared to the same quarter last year. Encompass Health has set its FY 2026 guidance at 5.890-6.110 EPS. As a group, analysts predict that Encompass Health Corporation will post 5.96 earnings per share for the current year.

Encompass Health Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Wednesday, July 15th. Shareholders of record on Wednesday, July 1st were given a dividend of $0.19 per share. The ex-dividend date of this dividend was Wednesday, July 1st. This represents a $0.76 annualized dividend and a yield of 0.7%. Encompass Health’s dividend payout ratio is presently 12.69%.

Wall Street Analysts Forecast Growth

Several research firms recently weighed in on EHC. Weiss Ratings cut shares of Encompass Health from a “buy (b-)” rating to a “hold (c+)” rating in a research report on Friday, June 26th. Leerink Partners set a $152.00 price target on shares of Encompass Health in a research note on Friday, May 22nd. Wall Street Zen raised shares of Encompass Health from a “hold” rating to a “buy” rating in a report on Saturday, May 2nd. Barclays dropped their price objective on shares of Encompass Health from $153.00 to $140.00 and set an “overweight” rating for the company in a report on Tuesday, May 5th. Finally, TD Cowen began coverage on Encompass Health in a research note on Thursday, May 28th. They issued a “buy” rating and a $125.00 target price on the stock. One research analyst has rated the stock with a Strong Buy rating, six have given a Buy rating and two have assigned a Hold rating to the company. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $143.86.

Insider Transactions at Encompass Health

In other Encompass Health news, EVP Patrick William Tuer sold 682 shares of the firm’s stock in a transaction on Monday, May 11th. The shares were sold at an average price of $104.56, for a total value of $71,309.92. Following the sale, the executive vice president owned 24,755 shares of the company’s stock, valued at $2,588,382.80. This trade represents a 2.68% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 1.80% of the stock is currently owned by company insiders.

About Encompass Health

Encompass Health Corporation is a leading provider of post?acute healthcare services in the United States, operating a comprehensive network of inpatient rehabilitation hospitals and home health and hospice agencies. Its inpatient rehabilitation hospitals offer intensive therapy programs for patients recovering from conditions such as stroke, brain injury, spinal cord injury, cardiac and pulmonary disorders, and orthopedic procedures. Through its home health segment, Encompass Health delivers skilled nursing, physical therapy, occupational therapy and speech therapy to patients in the comfort of their homes, while its hospice services provide end?of?life care focused on symptom management and emotional support for patients and families.

Founded in 1984 as HealthSouth Corporation and rebranded as Encompass Health in 2018, the company has grown organically and through acquisitions to serve patients across more than 30 states.